You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The immune system in cancer metastasis: friend or foe?
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, October 2017
|
| DOI | 10.1186/s40425-017-0283-9 |
| Pubmed ID | |
| Authors |
Louise M.E. Janssen, Emma E. Ramsay, Craig D. Logsdon, Willem W. Overwijk |
| Abstract |
Metastatic disease is the leading cause of death among cancer patients and involves a complex and inefficient process. Every step of the metastatic process can be rate limiting and is influenced by non-malignant host cells interacting with the tumor cell. Over a century ago, experiments first indicated a link between the immune system and metastasis. This phenomenon, called concomitant immunity, indicates that the primary tumor induces an immune response, which may not be sufficient to destroy the primary tumor, but prevents the growth of a secondary tumor or metastases. Since that time, many different immune cells have been shown to play a role in both inhibiting and promoting metastatic disease. Here we review classic and new observations, describing the links between the immune system and metastasis that inform the development of cancer therapies. |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 47% |
| Turkey | 1 | 3% |
| Canada | 1 | 3% |
| Chile | 1 | 3% |
| Spain | 1 | 3% |
| Italy | 1 | 3% |
| Ireland | 1 | 3% |
| China | 1 | 3% |
| Colombia | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 11 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 66% |
| Scientists | 6 | 16% |
| Practitioners (doctors, other healthcare professionals) | 5 | 13% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 388 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 388 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 66 | 17% |
| Student > Bachelor | 62 | 16% |
| Student > Master | 48 | 12% |
| Researcher | 39 | 10% |
| Student > Postgraduate | 18 | 5% |
| Other | 44 | 11% |
| Unknown | 111 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 96 | 25% |
| Medicine and Dentistry | 46 | 12% |
| Immunology and Microbiology | 33 | 9% |
| Agricultural and Biological Sciences | 31 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 3% |
| Other | 44 | 11% |
| Unknown | 127 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2022.
All research outputs
#1,661,136
of 25,382,440 outputs
Outputs from Journal for Immunotherapy of Cancer
#424
of 3,422 outputs
Outputs of similar age
#32,783
of 335,962 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#9
of 24 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,422 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,962 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.